Israel Englander Mirati Therapeutics, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $18.8 Million - $27.9 Million	-446,683 Reduced 88.4%	58,626 $3.44 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $17.6 Million - $24.1 Million	486,275 Added 2554.77%	505,309 $18.3 Million
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $4.74 Million - $7.04 Million	-129,766 Reduced 87.21%	19,034 $708,000
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $5.68 Million - $13.6 Million	137,588 Added 1227.15%	148,800 $6.74 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $11.9 Million - $17.3 Million	-199,228 Reduced 94.67%	11,212 $783,000
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $3.53 Million - $7.99 Million	90,068 Added 74.82%	210,440 $14.1 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $3.22 Million - $6.41 Million	42,444 Added 54.47%	120,372 $9.9 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $3.5 Million - $5.04 Million	26,487 Added 51.49%	77,928 $11.4 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $58.2 Million - $78.2 Million	-440,796 Reduced 89.55%	51,441 $9.1 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $53.3 Million - $66.5 Million	369,794 Added 302.01%	492,237 $79.5 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $14.5 Million - $20.3 Million	91,491 Added 295.59%	122,443 $21 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $1.91 Million - $2.83 Million	11,764 Added 61.31%	30,952 $6.8 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $2.17 Million - $3.21 Million	19,188 New	19,188 $3.19 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $2.94 Million - $4.92 Million	-40,863 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $2.38 Million - $3.97 Million	34,121 Added 506.1%	40,863 $3.14 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $337,312 - $614,275	-4,767 Reduced 41.42%	6,742 $869,000
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $11.5 Million - $16.2 Million	-147,669 Reduced 92.77%	11,509 $896,000
Q2 2019 Aug 15, 2019	BUY	$59.49 - $104.71 $9.26 Million - $16.3 Million	155,702 Added 4479.34%	159,178 $16.4 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $206,787 - $363,971	3,476 New	3,476 $298,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $1.36 Million - $2.02 Million	-42,599 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $16 Million - $21.3 Million	-339,325 Reduced 88.85%	42,599 $2.01 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $6.57 Million - $13.3 Million	381,924 New	381,924 $11.7 Million
Q4 2017 Feb 14, 2018	SELL	$12.65 - $19.0 $5.64 Million - $8.47 Million	-445,709 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.7 - $11.7 $2.09 Million - $5.21 Million	445,709	445,709 $5.22 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account